Physician-Owned Distributorships: When Implant Profit Follows the Referral

Physician owned distributorship kickbacks turn the profit on a surgeon’s chosen implants into payment for choosing them. In these schemes, the surgeon earns through a device supplier, directs the hospital’s purchases, and helps generate claims to Medicare and other government health programs. The hospital buys the implant. The surgeon’s business collects the margin. For someone inside purchasing, device sales or the physician’s practice, the important connection may be between an ordinary supplier invoice and the person deciding what goes into the patient.

How Physician-Owned Distributorships Earn From Device Choice

A physician-owned distributorship earns revenue from implants its physician owners order for their own patients. It can buy devices from an unrelated manufacturer and resell them to the hospital where an owner operates. The surgeon can influence both the purchase and the return on the investment.

The Department of Health and Human Services’ Office of Inspector General explains in its 2013 Special Fraud Alert on physician-owned entities why this market is unusually exposed to that conflict. Implantable devices are physician preference items: the surgeon may choose or strongly influence the brand and type while the hospital pays. Ownership puts that purchasing influence on the selling side of the transaction.

Manufacturers’ representatives can deliver and restock products, manage instrumentation and support the operating room. A distributor’s inventory, personnel and product evaluations show what the business contributes. The alert singles out shells that lack those functions and businesses that fail to oversee their distribution operations. The question reaches beyond whose name appears on the invoice to what the company does for its money. The Inspector General also focuses on unusually high returns where the physician takes little investment risk.

How Does Reimbursement Work for Medical Devices?

Medicare generally includes the implant’s cost in its payment for the hospital stay or procedure. The hospital can report device charges even when the implant has no separate payment. A distributor invoice and a Medicare claim therefore describe different parts of the same operation.

For an inpatient surgery, the hospital’s payment generally follows the diagnosis-related group assigned to the stay. In hospital outpatient care, packaging device costs into the procedure payment is also the default. We connect the purchase and implant records to the hospital’s claim, including the procedure and the reason for payment. The distributor’s profit can sit inside a hospital bill that never asks Medicare to pay that distributor directly.

Ownership Returns Can Put Pressure on Hospital Purchasing

Physician distributor profits tied to implant volume give the surgeon a financial reason to keep choosing the distributor’s products. The alert identifies arrangements in which the investment offered, the price paid for ownership or the distributions depend on the owner’s expected or actual device use.

The pressure can run in both directions. Owners may threaten to move their surgeries unless a hospital buys from their distributorship. The distributor may threaten to cut an owner’s distributions or buy back the ownership interest if the surgeon stops generating enough business.

A Senate Finance Committee analysis in 2016 found that, as a share of patients seen, POD surgeons performed surgery at a rate 44% higher than non-POD surgeons. The comparison concerns the decision to operate, which creates demand for the implants.

The Inspector General also examines whether a hospital buys from the distributorship to secure or keep referrals from its physician owners. The purchasing agreement, the promise of surgical volume and the ownership return can explain why a supplier won the account. In the schemes alleged below, taxpayers funded claims while patients faced the risks of device choices driven by profit.

The same Senate report described distributorships moving to smaller and more rural hospitals after hospitals and health systems adopted policies governing their purchases. A change of hospital could move the business without changing the financial incentive.

Disclosure matters alongside that behavior. The alert identifies concealed ownership as a suspect feature and says disclosure alone does not resolve the financial incentive. Who owns the supplier, who controls its accounts and how distributions change with implant orders are separate facts worth connecting.

The Anti-Kickback Statute reaches payments intended to influence purchases and recommendations paid for by federal health care programs. In a physician-owned distributorship scheme, the payment can arrive under the ordinary business name of a profit distribution. The reason for paying it is the point.

Nexus Spine and 4D Spine Put Other Owners on Paper, the Government Alleged

Nexus Spine, LLC and 4D Spine, LLC allegedly concealed the surgeon’s control behind other registered owners. The Justice Department’s February 2020 announcement alleged that a Colorado neurosurgeon arranged for third parties to hold the companies on paper while he controlled both the distributorships and their money.

According to the government, the distributors supplied rods, screws and cages for his surgeries and paid him improper benefits, causing false claims to Medicare, Medicaid and TRICARE. The surgeon and three companies paid $2.35 million to resolve those civil allegations.

Sky Ridge Medical Center, Castle Rock Adventist and Porter Adventist appear in the government’s account as hospitals where the surgeon operated. The allegedly concealed relationship was between the physician choosing the equipment and the distributors supplying it.

An employee who had worked in the physician’s practice and later at 4D Spine brought the whistleblower case.

Medical Designs and Sicage Had More Than One Way to Pay

Medical Designs LLC and Sicage LLC allegedly paid their surgeon-owner through profits on devices he used in surgery. The government alleged that Medical Designs also resold other manufacturers’ products, giving its owner a return on devices his own company had not developed.

The government’s complaint describes that resale business plainly:

The alleged selling opportunity followed the owner into the operating room. The complaint says Sicage sold its devices only to Sanford Health and only for that owner’s use. In that account, the surgeon supplied both the clinical choice and the company’s customer demand.

The Hospital Changed Suppliers, but the Margin Stayed, the Complaint Alleged

According to the same complaint, Sioux Falls Specialty Hospital notified the surgeon and Medical Designs that it would terminate the purchasing agreement over physician-ownership concerns. The government alleged that Medical Designs then used Innovative Medical Solutions, LLC as a middleman to resell Aegis products to the hospital for the surgeon’s operations.

The complaint alleged that Medical Designs bought pedicle screws for $300 each and resold them to the middleman for $750 each. It also alleged that the surgeon later described the resale to Sanford’s compliance investigator as cost plus a small administrative fee. The complaint’s purchase and resale prices told a different story about that fee.

For a hospital buyer, the change in the supplier’s name could leave the original owner’s financial interest in place. The government’s allegation followed the product and the margin through the extra company.

The Restaurant Was Another Payment Route, the Government Alleged

Medtronic USA allegedly funded meals and alcohol at Carnaval Brazilian Grill, a restaurant the surgeon owned with his wife, in exchange for his use of its SynchroMed II infusion pumps. The Justice Department’s account of the physician and POD settlement described benefits for the surgeon and his friends, colleagues and business partners.

The alleged restaurant payments sat beside the alleged device profits. Looking only at the distributor’s accounts would miss the separate benefit the government described.

The Settlements Followed Different Parts of the Arrangement

In May 2021, the Justice Department announced that the surgeon, Medical Designs and Sicage had agreed to a $4.4 million False Claims Act settlement covering alleged kickbacks and medically unnecessary procedures. The government alleged that the surgeon continued those procedures despite warnings from physician colleagues while profiting from the devices used.

The two companies separately agreed to $100,000 in Open Payments penalties to resolve allegations that they failed to report the physician’s ownership interests and payments to him. The civil settlement also provided for six-year exclusions from federal health care programs for the physician and each company.

The hospital and manufacturer had their own resolutions. Sanford Health’s October 2019 settlement was $20.25 million, resolving allegations that it continued billing despite warnings about the surgeon’s financial interests and unnecessary operations. When a hospital receives a warning about a surgeon’s ownership of its implant supplier, its purchasing and billing records can show what happened next.

Medtronic’s October 2020 resolution included an $8.1 million False Claims Act settlement over the alleged benefits and a separate $1.11 million Open Payments resolution.

Reliance Made Implant Use Part of the Ownership Deal, the Government Alleged

Reliance Medical Systems allegedly used physician-owned distributors to reward referrals and remove physicians who generated too little business. Its 2022 civil settlement required $1 million collectively from Reliance, its two PODs and two owners.

The government alleged that the distributors paid physicians based on referrals and made false statements to healthcare providers. An ownership interest could be taken away when the physician stopped producing the business it was meant to bring. That is the practical meaning of a return tied to implant use: the surgeon’s place in the company depends on the surgeon’s patients becoming its customers.

The criminal case against a surgeon involved with Apex Medical Technologies showed the clinical consequence. In his guilty plea, as described in the Justice Department’s account of the criminal case, the surgeon admitted that financial incentives caused him to use more spinal implants than medically necessary to increase Apex’s sales, injuring patients. The distributor earned from devices placed inside people who did not need them.

DS Medical Connected Implant Choices to a Partner-Owned Supplier, the Government Alleged

The DS Medical case shows why the connection between the payment and the government claim needs its own evidence. The government alleged that a surgeon arranged to use implants whose manufacturers paid commissions to DS Medical, a distributor owned by his fiancée. The financial benefit reached someone close to the person choosing the product.

The Eighth Circuit reversed a civil judgment against the defendants in July 2022. The court ordered a new trial because the jury received an incorrect instruction on the connection between kickbacks and claims, while holding that the evidence could support liability under a correct instruction.

DS Medical, Midwest Neurosurgeons, the surgeon and the distributor owner later settled collectively for $825,000 in March 2023. The later settlement resolved allegations of implant-manufacturer commissions in return for arranging product use.

The case connects directly to an insider’s records. The distribution agreement explains the payment. Orders and procedure records connect it to device use. The hospital claim shows what the government was asked to fund. We work across those records to establish how the financial arrangement affected the care and the claim.

What Evidence Is Needed to Prove Fraud?

The useful evidence connects who benefited, what the surgeon selected, what the hospital bought and what the government paid. Ownership and distribution records explain the financial interest. Supplier invoices, implant records and claims connect that interest to particular procedures.

The implant can be real while the claim conceals how its use was purchased. A Forensic Accountant’s Guide to the Most Potent Federal Laws Used Against Healthcare Fraud, published in the Journal of Forensic and Investigative Accounting in 2020, explains how claims for services actually provided can misrepresent compliance with payment requirements. The Medical Designs allegations put that distinction into practice: the devices went into patients, while the government alleged that profit payments bought the surgeon’s choice.

The Medical Designs complaint put the manufacturer’s price, the distributor’s resale price, the implant and hospital payment into the same account. The Colorado case connected the registered owners to the physician’s alleged actual control. Sanford’s settlement addressed billing that allegedly continued after warnings. Each supplies a different connection that someone inside the business may already understand.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

When You Know Who Earns From the Implant

If you can see the ownership return behind a surgeon’s implant choices, talk to our whistleblower experts about the supplier, the purchases and the payments. We build the case with you and bring in medical device fraud whistleblower lawyers who understand implant distribution and hospital claims. We stay beside you from that first conversation through the case.